metricas
covid
Buscar en
Revista Colombiana de Reumatología
Toda la web
Inicio Revista Colombiana de Reumatología Papel de la enfermedad periodontal en el desarrollo de entidades inflamatorias d...
Journal Information
Vol. 19. Issue 2.
Pages 84-91 (June 2012)
Share
Share
Download PDF
More article options
Vol. 19. Issue 2.
Pages 84-91 (June 2012)
Full text access
Papel de la enfermedad periodontal en el desarrollo de entidades inflamatorias de etiología autoinmune: implicaciones clínicas y desafíos terapéuticos
Role of periodontal disease in the development of autoimmune inflammatory entities clinical: implications and therapeutic challenges
Visits
4073
Wilson Bautista Molano1,
Corresponding author
wbatu@hotmail.com

Correspondencia.
, Sonia R. Unriza Puin2, Juan Carlos Munevar2, Gloria Lafaurie2, Rafael Raúl Valle Oñate1, María Consuelo Romero Sánchez2
1 Grupo Espondiloartropatías. Servicio de Reumatologíae Inmunología. Hospital Militar Central. Bogotá, Colombia
2 Unidad de Investigación Básica Oral. Universidad del Bosque. Bogotá, Colombia
This item has received
Article information
Resumen

Durante la última década el área de conocimiento relacionada con la patogénesis de infecciones odontogénicas y su posible asociación con enfermedades sistémicas ha sido de gran interés. Patógenos periodontal es que ingresan al torrente sanguíneo se encuentran implicados en efectos patológicos sistémicosy esto ha llevado al desarrollo de la Teoría de Infección Focal, que se basa en la correlación fisiopatológica entre periodontitis crónica y ciertas enfermedades autoinmunes.

La artritis reumatoide, como enfermedad inflamatoria, se caracteriza por sinovitis persistente, destrucción del cartílago y del hueso. Su etiología es incierta, pero ciertos microorganismos pueden jugar un papel importante en la pérdida de autotolerancia y desarrollo de autoinmunidad. P. gingivalis puede estar comprometida en la amplificación de la respuesta inmune en individuos susceptibles genéticamente. Surge, entonces, el concepto de medicina periodontal como una disciplina que integra dichas asociaciones.

Palabras clave:
infección focal
dental
periodontitis crónica
inflamación
artritis reumatoide
Summary

During the last decade the knowledge related to the pathogenesis of odontogenic infections and their possible association with systemic diseases has been of great interest. Periodontal pathogens that enter to bloodstream are involved in systemic pathological effects. The Focal Infection Theory is based on the pathophysiology correlation between chronic periodontitis and the development of certain autoimmune diseases.

Rheumatoid arthritis as inflammatory disease is characterized by persistent synovitis and destruction of cartilage and bone. The etiology is uncertain, but some microorganisms may play important role in the lack of self-tolerance and the consequent development of autoimmunity. P. gingivalis may be involved in amplifying the immune response and induction of the disease in individuáis with genetic susceptibility. Therefore, the concept of periodontal medicine as a discipline to intégrate these associations has emerged.

Key words:
focal infection
dental
periodontitis
inflammation
arthritis rheumatoid
Full text is only aviable in PDF
Referencias
[1.]
P.G. O’Reilly, N.M. Claffey.
A history of oral sepsis as a cause of disease.
Periodontol, 23 (2000), pp. 13-18
[2.]
W.D. Miller.
The human mouth as a focus of infection. Dental Cosmos.
J Am Dent Assoc, 33 (1891), pp. 689-713
[3.]
W. Hunter.
Oral sepsis as a cause of disease.
Br Med J, 2 (1900), pp. 215-216
[4.]
W. Hunter.
The role of sepsis and antisepsis in medicine.
Lancet, 1 (1910), pp. 79-86
[5.]
C.H. Mayo.
Focal infection of dental origin. Dental Cosmos.
J Am Dent Assoc, 64 (1922), pp. 1206-1208
[6.]
R.L. Cecil, D.M. Angevine.
Clinical and experimental observations on focal infection with an analysis of 200 cases of rheumatoid arthritis.
Ann Intern Med, 12 (1938), pp. 577-584
[7.]
Editorial.
FOCAL infection.
J Am Med Assoc, 150 (1952), pp. 490-500
[8.]
K.J. Manila, M.S. Nieminen, W. Valtonen, V.P. Rasi, Y.A. Kesaniemo, S.L. Syrjala, et al.
Association between dental health and acute myocardial infarction.
Brit Med J, 298 (1989), pp. 779-781
[9.]
F. DeStefano, R.F. Anda, H.S. Kahn, D.F. Williamson, C.M. Russell.
Dental disease and risk of coronary heart disease and mortality.
Brit Med J, 306 (1993), pp. 688-691
[10.]
D.F. Kinane, G.J. Marshall.
Periodontal manifestations of systemic disease.
Aust Dent J, 46 (2001), pp. 2-12
[11.]
S. Offenbacher.
Periodontal diseases: pathogenesis.
Ann Periodontol, l (1996), pp. 821-878
[12.]
F.A. Scannapieco.
Position paper of the American Academy of Periodontology: periodontal disease as a potential risk factor for systemic diseases.
J Periodontol, 69 (1998), pp. 84l-850l
[13.]
G.J. Seymour, P.J. Ford, M.P. Cullinan, S. Leishman, K. Yamazaki.
Relationship between periodontal infections and systemic disease.
Clin Microbiol Infect, 13 (2007), pp. 3-10
[14.]
G.C. Armitage.
Development of a classification system for periodontal diseases and conditions.
Ann Periodontol, 4 (1999), pp. l-l6
[15.]
G. Pizzo, R. Guiglia, L. Russo, G. Campisi.
Dentistry andinternal medicine: from the focal infection theory to the periodontal medicine concept.
Eur J Intern Med, 21 (2010), pp. 496-502
[16.]
S.S. Socransky, A.D. Haffajee.
Periodontal microbial ecology.
Periodontol, 38 (2000), pp. 135-187
[17.]
L.C. Kuo, A.M. Polson, T. Kang.
Associations between periodontal diseases and systemic diseases: a review of the inter-relationships and interactions with diabetes, respiratory diseases, cardiovascular diseases and osteoporosis.
Public Health, 122 (2008), pp. 4l7-33l
[18.]
P. Li, L. He, Y.Q. Sha, Q.X. Luán.
Relationship of metabolic syndrome to chronic periodontitis.
J Periodontol, 80 (2009), pp. 541-549
[19.]
A.R. Kamer, A.P. Dasanayake, R.G. Craig, L. Glodzik-Sobanska, M. Bry, M.J. de León.
Alzheimer's disease and peripheral infections: the possible contribution from periodontal infections, model and hypothesis.
J Alzheimers Dis, 13 (2008), pp. 437-449
[20.]
P.M. Bartold, R.I. Marshall, D.R. Haynes.
Periodontitis and rheumatoid arthritis: a review.
J Periodontol, 76 (2005), pp. 2066-2074
[21.]
P. De Pablo, T. Dietrich, T.E. McAlindon.
Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population.
J Rheumatol, 35 (2008), pp. 70-76
[22.]
F.B. Mercado, R.I. Marshall, A.C. Klestov, P.M. Bartold.
Relationship between rheumatoid arthritis and periodontitis.
J Periodontol, 72 (2001), pp. 779-787
[23.]
F.B. Mercado, R.I. Marshall, P.M. Bartold.
ínter-relationships between rheumatoid arthritis and periodontal disease. A review.
J Clin Periodontol, 30 (2003), pp. 761-772
[24.]
L.N. Borrell, B.A. Burt, G.W. Taylor.
Prevalen ce and trends in periodontitis in the USA: the [corrected] NHANES, 1988 to 2000.
J Dent Res, 84 (2005), pp. 924-930
[25.]
N. Pischon, T. Pischon, J. Kroger, E. Gulmez, B.M. Kleber, J.P. Berni-moulin, et al.
Association among rheumatoid arthritis, oral hygiene, and periodontitis.
J Periodontol, 79 (2008), pp. 979-986
[26.]
D.N. Tatakis, P.S. Kumar.
Etiology and pathogenesis of periodontal diseases.
Dent Clin North Am, 49 (2005), pp. 491-516
[27.]
T.R. Mikuls, J.B. Payne, R.A. Reinhardt, G.M. Thiele, E. Maziarz, A.C. Cannella, et al.
Antibody responses to Porphyromonas gingivalis (R gingivalis) in subjects with rheumatoid arthritis and periodontitis.
Int Immunopharmacol, 9 (2009), pp. 38-42
[28.]
L. Klareskog, J. Rónnelid, K. Lundberg, L. Padyukov, L. Al- fredsson.
Immunity to citrullinated proteins in rheumatoid arthritis.
Annu Rev Immunol, 26 (2008), pp. 651-675
[29.]
N. Wegner, K. Lundberg, A. Kinloch, B. Fisher, V. Malmstrom, M. Feldmann, et al.
Autoimmunity to citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis.
Immunol Rev, 233 (2010), pp. 34-54
[30.]
K. Lundberg, N. Wegner, T. Yucel-Lindberg, P. Venables.
Periodontitis in RA-the citrullinated enolase connection.
Nat Rev Rheumatol, 6 (2010), pp. 727-730
[31.]
E.D. Rosenstein, R.A. Greenwald, L.J. Kushner, G. Weissmann.
Hypothesis: the humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis.
Inflammation, 28 (2004), pp. 311-318
[32.]
P. Mangat, N. Wegner, P. Venables, J. Potempa.
Bacterial and human peptidylarginine deiminases targets for inhibiting the autoinmune response in rheumatoid arthritis?.
Arthritis Res Ther, 12 (2010), pp. 209-218
[33.]
N. Wegner, K. Lundberg, A. Kinloch, B.A. Fisher, V. Malmstrom, M. Feldmann, et al.
Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis.
Immunol Rev, 233 (2010), pp. 34-54
[34.]
A.V. Colombo, C.M. Da Silva, A. Haffajee, A.P. Colombo.
Identification of intracellular oral species within human crevicular epithelial cells from subjects with chronic periodontitis by fluorescence in situ hybridization.
J. Periodontal Res, 42 (2007), pp. 236-243
[35.]
G. Lafaurie, A. Contreras, A. Barón, J. Botero, I. Mayorga-Fayad, A. Jaramillo, et al.
Demographic, clinical and microbial aspects of chronic and aggressive periodontitis in Colombia: A multicenter study.
J. Periodontol, 78 (2007), pp. 629-639
[36.]
J. Potempa, A. Sroka, T. Imamura, J. Travis.
Gingipains, the major cysteine proteinases and virulence factors of Porphyromonas gingivalis: structure, function and assembly of multidomain protein complexes.
Curr Protein Pept Sci, 4 (2003), pp. 397-407
[37.]
D.M. Castillo, M.C. Sánchez-Beltrán, J.E. Castellanos, I. Sanz, I. Mayorga-Fayad, M. Sanz, et al.
Detection of specific periodontal microorganisms from bacteraemia samples after periodontal therapy using molecular-based diagnostics.
J Clin Periodontol, 38 (2011), pp. 4l8-27l
[38.]
S. Chavanas, M.C. Mechin, H. Takahara, A. Kawada, R. Nachat, G. Serré, et al.
Comparative analysis of the mouse and human peptidylarginine deiminase gene clusters reveáis highly conserved non-coding segments and a new human gene. PADI6.
[39.]
W.T. McGraw, J. Potempa, D. Farley, J. Travis.
Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase.
Infect Immun, 67 (1999), pp. 3248-3256
[40.]
N. Wegner, R. Wait, A. Sroka, S. Eick, K.A. Nquyen, K. Lundberg, et al.
Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and alpha-enolase: implications for autoimmunity in rheumatoid arthritis.
Arthritis Rheum, 62 (2010), pp. 2662-2672
[41.]
IrelandJ, UnanueE.R. HerzogJ.
Cuttingedge: uniqueTcells that recognize citrullinated peptides are a feature of protein immunization.
J. Immunol, 177 (2006), pp. l421-l425
[42.]
D. Makrygiannakis, E. af Klint, I.E. Lundberg, R. Lofberg, A.K. Ulfgren, L. Klareskog, et al.
Citrullination is an inflammation-dependent process.
Ann Rheum Dis, 65 (2006), pp. 1219-1222
[43.]
L. Klareskog, RonnelidJ, K. Lundberg, L. Padyukov, L. Alfredsson.
Immunity to citrullinated proteins in rheumatoid arthritis.
Annu Rev Immunol, 26 (2008), pp. 651-675
[44.]
R. Valle-Oñate, L. Candía, C. Romero-Sánchez, A. Iglesias- Gamarra, C.V. Caballero-Uribe, et al.
Epidemiology of spondyloarthritis in Colombia.
Am J Med Sci, 341 (2011), pp. 293-294
[45.]
C. Romero-Sánchez, H.K. Tsou, M.S. Jan, R.H. Wong, I.C. Chang, J. Londoño, et al.
Serum monocyte chemotacticprotein-1 concentrations distínguish patients with ankylosing spondylitis from patients with mechanical low back pain.
J Spinal Disord Tech, 24 (2011), pp. 202-207
[46.]
E.R. Vossenaar, T.J. Smeets, M.C. Kraan, J.M. Raats, W.J. van Ven- ooij, P.R. Tak.
The presence of citrullinated proteins is not specific for rheumatoid tissue.
Arthritis Rheum, 50 (2004), pp. 3485-3494
[47.]
A. Beltrami, M. Rossman, M. Fiorillo, F. Paladina, R. Sorrentino, W. Saenger, et al.
Citrullination-dependent differential presentation of a self-peptide by HLA-B27 subtypes.
J Biol Chem, 283 (2008), pp. 27189-27199
[48.]
E. Brahn, C. Tang, M.L. Banquerigo.
Regression of collageninduced arthritis with taxol, a microtubule stabilizer.
Arthritis Rheum, 37 (1994), pp. 839-845
[49.]
L.B. Pritzker, M.A. Moscarello.
A novel microtubule independent efect of paclitaxel: the inhibitíon of peptidylarginine deiminase frombovinebrain.
Biochim Biophys Acta, 1388 (1998), pp. 154-160
[50.]
D. Lainer-Carr, E. Brahn.
Angiogenesis inhibitíon as a therapeutic approach for inflammatory synovitis.
Nat Clin Pract Rheumatol, 3 (2007), pp. 434-442
[51.]
Y. Luo, K. Arita, M. Bhatia, B. Knuckley, Y.H. Lee, M.R. Stallcup.
Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization.
Biochemistry, 45 (2006), pp. 11727-11736
[52.]
V.C. Willis, A.M. Gizinski, N.K. Banda, C.P. Causey, B. Knuckley, K.N. Cordova, et al.
N-alfa-benzoyl-N5-(2-chlorol-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis.
J Immunol, 186 (2011), pp. 4396-4404
[53.]
B. Knuckley, Y. Luo, P.R. Thompson.
Profiling Protein Arginine Deiminase 4 (PAD4): a novel screen to identify PAD4 inhibitors.
Bioorg Med Chem, 16 (2008), pp. 739-745
[54.]
L. Li, Z. Li, D. Chen, X. Lu, X. Feng, E.C. Wright, et al.
Inactivation of microbial arginine deiminases by L-canavanine.
J Am Chem Soc, 130 (2008), pp. 1918-1931
Copyright © 2012. Asociación Colombiana de Reumatología
Download PDF
Article options